Tested Applications
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
22306-1-AP targets CCL24/Eotaxin 2 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | chemokine (C-C motif) ligand 24 |
| Calculated Molecular Weight | 13 kDa |
| Observed Molecular Weight | 13 kDa |
| GenBank Accession Number | NM_002991 |
| Gene Symbol | CCL24/Eotaxin 2 |
| Gene ID (NCBI) | 6369 |
| RRID | AB_2879068 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen Affinity purified |
| UNIPROT ID | O00175 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Chemokine CCL24 is the second member of eotaxins, a group of eosinophils' selectively chemoattractants. CCL24 is constitutively expressed in fibroblasts, epithelial cells, macrophages. CCL24 has only one receptor CCR3, which mainly presents on eosinophils and was also found on basophils, monocytes, Th2 lymphocytes, epithelial cells and airway smooth muscles. CCL24 displays chemotactic activity on resting T lymphocytes, a minimal activity on neutrophils, and is negative on monocytes and activated T lymphocytes.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for CCL24/Eotaxin 2 antibody 22306-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
22306-1-AP is the CCL24/Eotaxin 2 Polyclonal antibody, with 8 total citations across journals including Cell Death Dis, Clin Transl Med, Sci Rep, J Inflamm Res, Kidney360, Dis Markers, bioRxiv, and Mol Cell Biol. Research fields covered include skin fibrosis, colorectal cancer progression, peritoneal dialysis fibrosis, sepsis-induced lung injury, kidney disease (Alport syndrome and podocyte inflammation), and sarcoidosis. Applications cited include IHC, IF, and WB across mouse, human, and rat samples.
| Species | Application | Title |
|---|---|---|
Cell Death Dis Mechanical stiffness promotes skin fibrosis via Piezo1-Wnt2/Wnt11-CCL24 positive feedback loop | ||
Clin Transl Med NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization | ||
Sci Rep Peritoneal MSCs-derived exosomes suppress CCL24 synthesis through miR-320d delivery contributing to the improvement of peritoneal dialysis-associated fibrosis. | ||
J Inflamm Res Plasma Exosomal miR-17-5p Regulates Macrophage Polarization by Targeting Bcl11b in Sepsis-Induced Lung Injury. | ||
Kidney360 Dotinurad, a Novel Urate Reabsorption Inhibitor, Prolongs Survival in Alport Mice. | ||







